Analyst Ratings For NASDAQ:CKPT – Checkpoint Therapeutics (NASDAQ:CKPT)

Today, HC Wainwright reiterated its Buy rating on NASDAQ:CKPT – Checkpoint Therapeutics (NASDAQ:CKPT) with a price target of $11.00.

Some recent analyst ratings include

• 5/11/2018-HC Wainwright Reiterated Rating of Buy.
• 3/22/2017-Ladenburg Thalmann initiated coverage with a Buy rating.

Recent Insider Trading Activity For NASDAQ:CKPT – Checkpoint Therapeutics (NASDAQ:CKPT)
NASDAQ:CKPT – Checkpoint Therapeutics (NASDAQ:CKPT) has insider ownership of 8.70% and institutional ownership of 0.56%.

Recent Trading Activity for NASDAQ:CKPT – Checkpoint Therapeutics (NASDAQ:CKPT)
Shares of NASDAQ:CKPT – Checkpoint Therapeutics closed the previous trading session at with 3.490000009536743 shares trading hands.